Literature DB >> 15020651

Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix.

Wilson Savino1, Daniella Arêas Mendes-Da-Cruz, Salete Smaniotto, Elizângela Silva-Monteiro, Déa Maria Serra Villa-Verde.   

Abstract

Cell migration is crucial for thymocyte differentiation, and the cellular interactions involved now begin to be unraveled, with chemokines, extracellular matrix (ECM) proteins, and their corresponding receptors being relevant in such oriented movement of thymocytes. This notion derives from in vitro, ex vivo, and in vivo experimental data, including those obtained in genetically engineered and spontaneous mutant mice. Thymic microenvironmental cells produce both groups of molecules, whereas developing thymocytes express chemokine and ECM receptors. It is important that although chemokines and ECM proteins can drive thymocyte migration per se, a combined role of these molecules likely concurs for the resulting migration patterns of thymocytes in their various differentiation stages. In this respect, among ECM moieties, there are proteins with opposing functions, such as laminin or fibronectin versus galectin-3, which promote, respectively, adhesion and de-adhesion of thymocytes to the thymic microenvironment. How chemokines and ECM are produced and degraded remains to be more clearly defined. Nevertheless, matrix metalloproteinases (MMPs) likely play a role in the intrathymic ECM breakdown. It is interesting that these molecules also degrade chemokines. Thus, the physiological migration of thymocytes should be conceived as a resulting vector of multiple, simultaneous, or sequential stimuli, involving chemokines, adhesive, and de-adhesive ECM proteins. Moreover, these interactions may be physiologically regulated in situ by matrix MMPs and are influenced by hormones. Accordingly, one can predict that pathological changes in any of these loops may result in abnormal thymocyte migration. This actually occurs in the murine infection by the protozoan Trypanosoma cruzi, the causative agent of Chagas disease. In this model, the abnormal release of immature thymocytes to peripheral lymphoid organs is correlated with the higher migratory response to ECM and chemokines. Lastly, the fine dissection of the mechanisms governing thymocyte migration will provide new clues for designing therapeutic strategies targeting developing T cells. The most important function of the thymus is to generate T lymphocytes, which once leaving the organ, are able to colonize specific regions of peripheral lymphoid organs, the T cell zones, where they can mount and regulate cell-mediated, immune responses. This intrathymic T cell differentiation is a complex sequence of biological events, comprising cell proliferation, differential membrane protein expression, gene rearrangements, massive programmed cell death, and cell migration. In this review, we will focus on the mechanisms involved in controlling the migration of thymocytes, from the entrance of cell precursors into the organ to the exit of mature T cells toward peripheral lymphoid organs. Nevertheless, to better comprehend this issue, it appeared worthwhile to briefly comment on some key aspects of thymocyte differentiation and the tissue context in which it takes place, the thymic microenvironment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020651     DOI: 10.1189/jlb.1003455

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  47 in total

1.  The thymus microenvironment in regulating thymocyte differentiation.

Authors:  Jacy Gameiro; Patrícia Nagib; Liana Verinaud
Journal:  Cell Adh Migr       Date:  2010-07-15       Impact factor: 3.405

Review 2.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

3.  Immunohistochemical study of a membrane skeletal molecule, protein 4.1G, in mouse seminiferous tubules.

Authors:  Nobuo Terada; Nobuhiko Ohno; Hisashi Yamakawa; Osamu Ohara; Xiaogang Liao; Takeshi Baba; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2005-10-28       Impact factor: 4.304

4.  Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection.

Authors:  Elizangela Silva-Monteiro; Luciana Reis Lorenzato; Oscar Kenji Nihei; Mara Junqueira; Gabriel Adrián Rabinovich; Daniel Kaiyuan Hsu; Fu-Tong Liu; Wilson Savino; Roger Chammas; Déa Maria Serra Villa-Verde
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

5.  Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.

Authors:  Romina P Muiá; Hai Yu; Jennifer A Prescher; Ulf Hellman; Xi Chen; Carolyn R Bertozzi; Oscar Campetella
Journal:  Glycobiology       Date:  2010-03-30       Impact factor: 4.313

6.  Real Time In Vivo Tracking of Thymocytes in the Anterior Chamber of the Eye by Laser Scanning Microscopy.

Authors:  Elisa Oltra; Alejandro Caicedo
Journal:  J Vis Exp       Date:  2018-10-02       Impact factor: 1.355

Review 7.  Tracking migration during human T cell development.

Authors:  Joanna Halkias; Heather J Melichar; Kayleigh T Taylor; Ellen A Robey
Journal:  Cell Mol Life Sci       Date:  2014-03-30       Impact factor: 9.261

8.  Development of pipette tip gap closure migration assay (s-ARU method) for studying semi-adherent cell lines.

Authors:  Swapnil Ganesh Sanmukh; Sérgio Luis Felisbino
Journal:  Cytotechnology       Date:  2018-08-01       Impact factor: 2.058

9.  MMP9 is protective against lethal inflammatory mass lesions in the mouse colon.

Authors:  Andreas Hald; Birgitte Rønø; Maria C Melander; Ming Ding; Susanne Holck; Leif R Lund
Journal:  Dis Model Mech       Date:  2010-12-01       Impact factor: 5.758

10.  A cellular automata-based mathematical model for thymocyte development.

Authors:  Hallan Souza-e-Silva; Wilson Savino; Raúl A Feijóo; Ana Tereza Ribeiro Vasconcelos
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.